ARAY 250117 4.00C (ARAY250117C4000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Jan 8 09:30 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Rocket KY

Jan 6 09:49

$Accuray (ARAY.US)$ ready

Moomoo News Global

Jan 6 02:12

Columns Is the Robotics Industry Poised for a Surge in 2025? Here Are the Investment Opportunities

Scheduled to officially start on January 7, 2025, the Consumer Electronics Show (CES)—a premier tech event that showcases both current products and futuristic concepts from large and small tech firms—once again captured global attention.
At CES 2025, $NVIDIA (NVDA.US)$ is undoubtedly one of the brightest stars on stage. Jensen Huang will personally showcase the company's latest breakthroughs in AI, robotics...

The CES showcase is here! Where's the next breakthrough in AI?

109

186

Trytosaveabit

Dec 18, 2024 06:46

Update

$Accuray (ARAY.US)$ Accuray's CyberKnife System Offers Promising Outcomes For Brainstem Metastases, Highlighting Safety And Precision
Benzinga· just
Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications

Trytosaveabit

Oct 17, 2024 06:13

Update

$Accuray (ARAY.US)$ Accuray Announced That Results Of The Pace-B– Prostate Advances In Comparative Evidence – Trial Were Published In The New England Journal Of Medicine
Benzinga· 3 mins ago
The research builds on previously reported data and shows that at five years, stereotactic body radiation therapy (SBRT) provides comparable rates of cancer control, tolerability and sexual functioning to conventional radiotherapy (CRT), while reducing the overall treatment timeframe from up to 39 days ...

Trytosaveabit

Sep 10, 2024 16:39

News

$Accuray (ARAY.US)$ Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
8 MINUTES AGO, 5:30 PM EDT
VIA PR NEWSWIRE
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments
MADISON, Wis., Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural Gene...